Expanding the armory for treating lymphoma: Targeting redox cellular status through thioredoxin reductase inhibition by Sicong Wang, Giovanna Di Trapani, Kathryn F. Tonissen

Get full text

The Effect of BCR-ABL Specific Tyrosine Kinase Inhibitors on the Thioredoxin System in Chronic Myeloid Leukemia by Erin Clapper, Giovanna Di Trapani, Kathryn F. Tonissen

Get full text

Co-Targeting of BTK and TrxR as a Therapeutic Approach to the Treatment of Lymphoma by Sicong Wang, Erin Clapper, Kathryn F. Tonissen, Giovanna Di Trapani

Get full text

Cross-talk between two antioxidants, thioredoxin reductase and heme oxygenase-1, and therapeutic implications for multiple myeloma by Prahlad V. Raninga, Giovanna Di Trapani, Slavica Vuckovic, Kathryn F. Tonissen

Get full text

Investigating the Thioredoxin and Glutathione Systems’ Response in Lymphoma Cells after Treatment with [Au(d2pype)2]Cl by Sicong Wang, Yaoying Lu, Kyra Woods, Giovanna Di Trapani, Kathryn F. Tonissen

Get full text

Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment by Erin Clapper, Sicong Wang, Prahlad V. Raninga, Giovanna Di Trapani, Kathryn F. Tonissen

Get full text

The thioredoxin system in breast cancer cell invasion and migration by Maneet Bhatia, Kelly L. McGrath, Giovanna Di Trapani, Pornpimol Charoentong, Fenil Shah, Mallory M. King, Frank M. Clarke, Kathryn F. Tonissen

Get full text

Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma by Jun Hui Sze, Prahlad V. Raninga, Kyohei Nakamura, Mika Casey, Kum Kum Khanna, Susan J. Berners-Price, Giovanna Di Trapani, Kathryn F. Tonissen

Get full text